Results 1 to 10 of about 7,491 (154)

The unexpected clot: unilateral brachial artery occlusion unmasking antithrombin III deficiency; case report and therapeutic considerations [PDF]

open access: yesThrombosis Journal
Background Antithrombin III (AT III) deficiency is a rare autosomal dominant thrombophilia that typically predisposes carriers to venous thromboembolism.
Mohammad Ameen Ishqair   +5 more
doaj   +2 more sources

Antithrombin III deficiency and idiopathic intracranial hypertension: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Idiopathic intracranial hypertension (IIH) is a condition where the pressure of the cerebrospinal fluid in the brain increases without a known cause.
Mansoureh Togha   +2 more
doaj   +2 more sources

A COVID‐19 case report with low ACT(activated clotting time) and high serum D‐dimer level: Antithrombin III deficiency? [PDF]

open access: yesRespirology Case Reports
The Coronavirus Disease 2019 (COVID‐19), caused by the virus named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), is a global public health problem in which atypical findings other than the usual fever and respiratory symptoms render early
Ayşe Şahin Tutak
doaj   +2 more sources

Genetic and clinical characterization of two families with severe venous thromboembolism due to nonsense mutations in the SERPINC1 gene [PDF]

open access: yesThrombosis Journal
Antithrombin (AT) III is a key physiological anticoagulant, and its hereditary deficiency represents one of the most severe forms of inherited thrombophilia.
Xuqian Wei   +3 more
doaj   +2 more sources

Hereditary Antithrombin Deficiency in Pediatric Patients: Pathophysiology, Clinical Features, Diagnosis, and Antithrombin Replacement Therapy [PDF]

open access: yesClinical and Applied Thrombosis/Hemostasis
Antithrombin (AT), a glycoprotein, plays a key role in anticoagulation by inhibiting coagulation proteases. It is also the primary mediator of heparin's anticoagulant effect, with heparin binding amplifying AT activity up to 1000-fold.
George M. Rodgers MD, PhD   +1 more
doaj   +2 more sources

Case report: A case of new mutation in SERPINC1 leading to thrombotic microangiopathy

open access: yesFrontiers in Genetics, 2023
Introduction: Hereditary antithrombin-III deficiency can significantly increase the risk for thrombosis, which is common in limb deep vein and pulmonary cases. However, thrombotic microangiopathy (TMA) caused by hereditary antithrombin deficiency is rare.
Bing Li   +6 more
doaj   +1 more source

Management of antithrombin III deficiency in pregnancy: a representative case and a literature review

open access: yesАкушерство, гинекология и репродукция, 2021
The work is aimed at discussing pregnancy management for the most thrombogenic genetic thrombophilia - antithrombin III (AT-III) deficiency. A detailed analysis of the literature and clinical case of pregnancy management in a patient with AT-III ...
S. V. Akinshina   +5 more
doaj   +1 more source

A Study of Prothrombotic Factors in Human Immunodeficiency Virus-Infected Patients

open access: yesIndian Journal of Medical Specialities, 2021
Introduction: Human immunodeficiency virus (HIV) infection has been described as a hypercoagulable state. Some studies suggest that thrombotic events may be 2–10 times more prevalent in this group than in the general population.
Meena Lanjiwar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy